Wang, Huawei
Alarcón, Christina N.
Liu, Bei
Watson, Felicia http://orcid.org/0000-0003-1468-5648
Searles, Stephen
Lee, Calvin K.
Keys, Jeremy
Pi, Willie http://orcid.org/0000-0001-8286-2955
Allen, Dale
Lammerding, Jan http://orcid.org/0000-0003-4335-8611
Bui, Jack D.
Klemke, Richard L. http://orcid.org/0000-0001-8230-2915
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | NIH Office of the Director (5T32 OD17863-4)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01 HL082792)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U54 CA210184, CA097022, CA184594, CA182495)
National Science Foundation (CBET-1254846)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM137605)
Hartwell Foundation
Center for Drug Discovery and Innovation at UC San Diego
Article History
Received: 3 November 2020
Accepted: 7 July 2021
First Online: 20 December 2021
Competing interests
: Cargocyte is the trademark of Cytonus Therapeutics. R.L.K. is the co-founder and equity holder of Cytonus Therapeutics. H.W. and R.L.K. are co-inventors of a related patent (WO 2019/032628 A1, US 10,927,349 B2) and H.W., W.P. and R.L.K. are co-inventors of another related patent (PCT/US21/016,919). Both patents were filed by UCSD.